<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - COVID-19 Vaccines from China and Russia Likely Ineffective
Image Overlay - COVID-19 Vaccines from China and Russia Likely Ineffective

COVID-19 Vaccines from China and Russia Likely Ineffective

COVID-19 Vaccines from China and Russia Likely Ineffective

According to experts, vaccines already approved in China and Russia may be largely ineffective. The vaccines, which did not go through a typical trial process, are based on a common cold virus that many people already have immunity to – rendering the vaccines less viable. This demonstrates the necessity of large-scale clinical trials prior to going to market. At Yourway, we provide everything needed to facilitate trials of all scales, from ancillary materials to transport, storage, and packing services.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?